Biocept - Model NGS - Next-Gen Sequencing Breast Panel - Liquid Biopsy Biomarker
From Target Selector NGS Panels
Combining Biocept’s Liquid Biopsy biomarker testing expertise with Oncomine™ from Thermo Fisher Scientific’s next-generation sequencing and decision support resources.
-
Most popular related searches
Products Details
- Exclusive, targeted and actionable
- Cost effective NGS-based solution
- Turn-around-time (7-10 days upon receipt of specimen in most cases)
- Sensitivity: 94.1-100% (MAF ≥0.1%)
- Raw data available for further research
- Specimen requirements: 8 mLs of peripheral blood in CEE-SURE™ or EDTA Tube
PD-L1, PR, ER, and AR expression testing available through Target Selector™ Circulating Tumor Cell (CTC) testing.
Customer reviews
No reviews were found for Biocept - Model NGS - Next-Gen Sequencing Breast Panel - Liquid Biopsy Biomarker. Be the first to review!